{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:35Z","timestamp":1786119575983,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/ijg.0b013e31821206cd","type":"journal-article","created":{"date-parts":[[2011,3,17]],"date-time":"2011-03-17T05:32:21Z","timestamp":1300339941000},"page":"326-330","source":"Crossref","is-referenced-by-count":9,"title":["Serum Antiphospholipid Antibody Levels in Pseudoexfoliation"],"prefix":"10.1097","volume":"21","author":[{"given":"Ozgul","family":"Altintas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nursen","family":"Yuksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulden Tamer","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berna","family":"Ozkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eeyda","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuf","family":"Caglar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210208","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0161-6420(98)96020-1","article-title":"Pseudoexfoliation syndrome for the comprehensive ophthalmologists: intraocular and systemic manifestations.","volume":"105","author":"Naumann","year":"1998","journal-title":"Ophthalmology"},{"key":"R2-7-20210208","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0039-6257(00)00196-X","article-title":"Exfoliation syndrome.","volume":"45","author":"Ritch","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"R3-7-20210208","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1001\/archopht.1991.01080040133044","article-title":"Electron-microscopic identification of pseudoexfoliation material in extrabulbar tissue.","volume":"109","author":"Schlotzer-Schrehardt","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"R5-7-20210208","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/archopht.1992.01080240097039","article-title":"Pseudoexfoliative fibrillopathy in visceral organs of a patient with pseudoexfoliation syndrome.","volume":"110","author":"Sreeteen","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"R6-7-20210208","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0002-9394(14)70908-0","article-title":"Association of pseudoexfoliation syndrome with increased vascular risk.","volume":"124","author":"Mitchell","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"R7-7-20210208","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(00)03645-X","article-title":"Pseudoexfoliation syndrome and aneurysms of the abdominal aorta.","volume":"357","author":"Schumacher","year":"2001","journal-title":"Lancet"},{"key":"R9-7-20210208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/sj.eye.6702177","article-title":"A possible link between the pseudoexfoliation syndrome and coronary artery disease.","volume":"21","author":"Citirik","year":"2007","journal-title":"Eye (Lond)"},{"key":"R10-7-20210208","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1536\/ihj.47.77","article-title":"Impaired systemic endothelial function in patients with pseudoexfoliation syndrome.","volume":"47","author":"Atalar","year":"2006","journal-title":"Int Heart J"},{"key":"R11-7-20210208","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0161-6420(01)00572-3","article-title":"Ocular hemodynamics in pseudoexfoliation syndrome and pseudoexfoliation glaucoma.","volume":"108","author":"Yuksel","year":"2001","journal-title":"Ophthalmology"},{"key":"R13-7-20210208","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000090578","article-title":"Magnetic resonance imaging of the brain in patients with pseudoexfoliation syndrome and glaucoma.","volume":"220","author":"Yuksel","year":"2006","journal-title":"Ophthalmologica"},{"key":"R14-7-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1055\/s-2008-1035088","article-title":"Pseudoexfoliation syndrome patients with branch and central retinal vein thrombosis.","volume":"211","author":"Cursiefen","year":"1997","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R17-7-20210208","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0002-9394(03)00077-1","article-title":"Plasma homocysteine is elevated in patients with exfoliation syndrome.","volume":"136","author":"Vessani","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"R18-7-20210208","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0002-9394(99)00255-X","article-title":"Cardiovascular and cerebrovascular mortality associated with ocular pseudoexfoliation.","volume":"129","author":"Shrum","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R19-7-20210208","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid antibody syndrome.","volume":"346","author":"Levine","year":"2002","journal-title":"N Engl J Med"},{"key":"R20-7-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0039-6257(02)00289-8","article-title":"Primary antiphospholipid antibody syndrome (APS): current concepts.","volume":"47","author":"Durrani","year":"2002","journal-title":"Surv Ophthalmol"},{"key":"R21-7-20210208","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0889-8588(02)00103-X","article-title":"Antiphospholipid thrombosis syndromes.","volume":"17","author":"Bick","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"R22-7-20210208","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/ard.48.5.358","article-title":"Antiphospholipid antibody: a risk factor for occlusive vascular disease in systemic lupus erythematous and the primary antiphospholipid syndrome.","volume":"48","author":"Anderson","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"R24-7-20210208","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archopht.1994.01090180088041","article-title":"Antiphospholipid antibodies in retinal vascular occlusions.","volume":"112","author":"Glacet-Bernard","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R25-7-20210208","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/eye.1991.10","article-title":"Vaso-occlusive retinopathy in the primary antiphospholipid syndrome.","volume":"5","author":"Acheson","year":"1991","journal-title":"Eye"},{"key":"R26-7-20210208","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00006982-199010000-00005","article-title":"Retinal and choroidal vaso-occlusive disease in systemic lupus erythematosus associated with antiphospholipid antibodies.","volume":"10","author":"Syners","year":"1990","journal-title":"Retina"},{"key":"R27-7-20210208","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/eye.1991.15","article-title":"Antiphospholipid antibodies in the aetiology of ischaemic optic neuropathy.","volume":"5","author":"Watts","year":"1991","journal-title":"Eye"},{"key":"R28-7-20210208","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0161-6420(88)33139-8","article-title":"Visual symptoms associated with the presence of a lupus anticoagulant.","volume":"95","author":"Levine","year":"1988","journal-title":"Ophthalmology"},{"key":"R29-7-20210208","first-page":"387","article-title":"Retinopatia proliferante y anticoagulante lupico.","volume":"55","author":"Garcia-Vicente","year":"1988","journal-title":"Arch Soc Esp Ophthalmol"},{"key":"R30-7-20210208","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00006982-198707040-00002","article-title":"Antiphospholipid antibodies associated with retinal vascular disease.","volume":"7","author":"Pulido","year":"1987","journal-title":"Retina"},{"key":"R31-7-20210208","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0161-6420(89)32825-9","article-title":"Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy).","volume":"96","author":"Kleiner","year":"1989","journal-title":"Ophthalmology"},{"key":"R32-7-20210208","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(98)10362-8","article-title":"Antiphospholipid antibodies and thrombosis.","volume":"353","author":"Greaves","year":"1999","journal-title":"Lancet"},{"key":"R33-7-20210208","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0897.1997.tb00301.x","article-title":"Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies.","volume":"38","author":"Del Papa","year":"1997","journal-title":"Am J Reprod Immunol"},{"issue":"suppl 2","key":"R34-7-20210208","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1177\/096120339800700211","article-title":"Beta2-glycoprotein I as a cofactor for anti-phospholipid reactivity with endothelial cells.","volume":"7","author":"Meroni","year":"1998","journal-title":"Lupus"},{"key":"R35-7-20210208","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/096120339600500521","article-title":"Antiphospholipid antibodies activate vascular endothelial cells.","volume":"5","author":"Simantov","year":"1996","journal-title":"Lupus"},{"key":"R36-7-20210208","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1182\/blood.V78.11.2894.2894","article-title":"Imbalance of thromboxaneprostacyclin biosynthesis in patients with lupus anticoagulant.","volume":"78","author":"Lellouche","year":"1991","journal-title":"Blood"},{"key":"R37-7-20210208","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1182\/blood.V80.12.3135.3135","article-title":"Activation of human platelets by the rabbit anticardiolipin antibodies.","volume":"80","author":"Lin","year":"1992","journal-title":"Blood"},{"key":"R38-7-20210208","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"C3 activation is required for antiphospholipid antibody-induced fetal loss.","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"key":"R39-7-20210208","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for antiphospholipid antibody mediated thrombophilia.","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R40-7-20210208","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9343(96)00060-5","article-title":"Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry.","volume":"100","author":"Finazzi","year":"1996","journal-title":"Am J Med"},{"issue":"suppl 2","key":"R41-7-20210208","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1177\/096120339800700228","article-title":"Regulatory mechanisms of transmembrane phospholipid distributions and pathophysiological implications of transbilayer lipid scrambling.","volume":"7","author":"Bevers","year":"1998","journal-title":"Lupus"},{"key":"R42-7-20210208","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/exmp.1999.2243","article-title":"Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome.","volume":"66","author":"Levine","year":"1999","journal-title":"Exp Mol Pathol"},{"key":"R43-7-20210208","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00001721-199210000-00004","article-title":"Lupus anticoagulantsanticardiolipin antibodies in patients with normal tension glaucoma.","volume":"3","author":"Tsakiris","year":"1992","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R44-7-20210208","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2249.2001.01578.x","article-title":"Antiphosphatidylserine antibodies are elevated in normal tension glaucoma.","volume":"125","author":"Kremmer","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"R45-7-20210208","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1136\/bjo.2003.040832","article-title":"Coincidence of normal tension glaucoma, progressive sensorineural hearing loss, and elevated antiphosphatidylserine antibodies.","volume":"88","author":"Kremmer","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R46-7-20210208","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/112067210601600407","article-title":"Homocysteine levels in plasma and sensorineural hearing loss in patients with pseudoexfoliation syndrome.","volume":"16","author":"Aydogan Ozkan","year":"2006","journal-title":"Eur J Ophthalmol"},{"key":"R47-7-20210208","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/sj.eye.6700011","article-title":"Pseudoexfoliation and sensorineural hearing loss.","volume":"16","author":"Cahill","year":"2002","journal-title":"Eye (Lond)"},{"key":"R48-7-20210208","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0196-0709(93)90075-I","article-title":"Anticardiolipin antibody-induced sudden profound sensorineural hearing loss.","volume":"14","author":"Hisashi","year":"1993","journal-title":"Am J Otolaryngol"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00061198-201206000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:54:08Z","timestamp":1786042448000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00061198-201206000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0b013e31821206cd","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}